Skip to content

Progesterone Receptor (PR) [SP2] API302AA

by Biocare Medical, LLC

Ref API302AA

Progesterone Receptor (PR) [SP2] API302AA is an in vitro diagnostic device (EU IVDD general IVD; FDA Class I; FDA product code MVU, Reagents, Specific, Analyte) made by Biocare Medical, LLC, registered in EUDAMED on 28 Oct 2026 (Basic UDI-DI B-00847627002112) and listed in FDA GUDID since 7 Dec 2022 (UDI-DI 00847627002112), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00847627002112 Basic UDI-DI 00847627002112UDI-DIDate28 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00847627002112 UDI-DI Date7 Dec 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00847627002112 registered 28 Oct 2026 Active
  • FDA GUDID UDI-DI 00847627002112 listed 7 Dec 2022 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00847627002112
  2. Registered EUDAMED B-00847627002112

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Progesterone Receptor (PR) [SP2]
Generic name
Estrogen (oestrogen)/progesterone receptor IVD, antibody
Model / reference
API302AA
Primary DI / UDI-DI
00847627002112
Basic UDI-DI
B-00847627002112
FDA product code
MVU
EMDN code
W0102030202 Progesterone receptor assays
GMDN term
Estrogen (oestrogen)/progesterone receptor IVD, antibody
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
864.4020
EU registration type
Legacy device (under a directive)
EU market of registration
Hungary
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under TUMOUR MARKERS.

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)